Company Overview
Isomab Ltd is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Friday 11 March 2022. Isomab Ltd has been in business for 4 years. The accounts status is micro entity and the accounts are next due on Thursday 31 December 2026.
Registered Address

St Johns Innovation Centre, Cowley Road, Cambridge, CB4 0WS
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameISOMAB LTD
Company Number13972139
Registered Office AddressSt Johns Innovation Centre
 Cowley Road
 CB4 0WS
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date11/03/2022
Accounting Reference Date Day31
Accounting Reference Date Month3
Accounts Next Due Date31/12/2026
Accounts Last Made Up Date31/03/2025
Accounts Account CategoryMICRO ENTITY
Returns Next Due Date08/04/2023
Directors & Members
Show Resigned
David Bates - Director
(British, 58 years old, born May 1968)
Appointed 11 March 2022
 Active
Philip Brainin - Director
(Danish, 35 years old, born December 1991)
Appointed 12 March 2026
 Active
Laura Davies - Director
(British, 37 years old, born May 1989)
Appointed 05 September 2024
 Active
Paul Edwards - Director
(British, 70 years old, born December 1956)
Appointed 01 July 2022
 Active
Shi Foo - Director
(American, 57 years old, born October 1969)
Appointed 17 February 2025
 Active
Anker Lundemose - Director
(Danish, 65 years old, born July 1961)
Appointed 01 April 2024
 Active
JR Needham - Director
(American, 63 years old, born November 1963)
Appointed 12 February 2024
 Active
Mercia Fund Management (Nominees) Limited - Director
Appointed 12 February 2024
 Active
Secretaries
Julian Attfield - Secretary
Appointed 24 July 2025
 Active
Other Company Directorships
David Bates
COULOIR JUNKIE CONSULTING LTD
EMENDA BIOLOGICS LTD
EMENDA THERAPEUTICS LTD
EXONATE LIMITED
Philip Brainin
No companies found
Laura Davies
BITROBIUS GENETICS LTD
Paul Edwards
ENTRUST RESOURCE SOLUTIONS LTD
EUROSELECTION LIMITED
NANOMAB TECHNOLOGY (UK) LIMITED
NANOMAB UK HOLDINGS LTD
OBN (UK) LTD
SCI SEARCH & SELECTION LIMITED
SUDBURY (SUFFOLK) & DISTRICT CRICKET CLUB C.I.C.
TAYLAN ADVISORY SERVICES LIMITED
Shi Foo
No companies found
Anker Lundemose
No companies found
JR Needham
No companies found
Mercia Fund Management (Nominees) Limited
AXIS SPINE TECHNOLOGIES LTD
BIOLOGICAL PREPARATIONS GROUP LIMITED
BROKER INSIGHTS LIMITED
CENTURO GLOBAL LIMITED
CHADDENWYCH SERVICES LIMITED
CLARILIS LIMITED
CULTUREAI LTD
ENATE GROUP LTD.
FORENSIC ANALYTICS LTD
IOPT HOLDINGS LTD
JRCC HOLDINGS LTD
LITIGATIONWARE LIMITED
LMC SOFTWARE LTD
LOCATE BIO LIMITED
MOONSHOT CVE HOLDINGS LTD
NAITIVE TECHNOLOGIES LIMITED
NAPO LIMITED
OCEANSAVER LTD
PROMETHEAN PARTICLES LIMITED
PURE PET FOOD LTD
RIDGE PHARMA LIMITED
RISK LEDGER LTD.
ROCKAR 2016 LIMITED
SHIELD SPACE LIMITED
SIMANALYTICA LIMITED
SOCIAL VALUE PORTAL LTD
SPACE AND TIME LIMITED
THANKS BEN LTD
THE PURPLE GROUP LIMITED
TURBINE SIMULATED CELL TECHNOLOGIES LTD
TUTORA LTD
UB INFRASTRUCTURE LTD
VOLUMATIC HOLDINGS LIMITED
VOXPOPME LIMITED
WOBBLE GENOMICS LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2023
Balance Sheet
Fixed Assets 1,679 1,679
Current Assets 568,325 568,325
Creditors Due Within One Year 126,116 126,116
Working Cap 442,209 442,209
Total Assets Less Current Liabilities 443,888 443,888
Long-term Liabilities 16,060 16,060
Net Assets 427,828 427,828
Share Capital & Reserves
Share Cap - -
Profit & Loss Reserves - -
Other Reserves - -
Shareholders Funds 427,828 427,828
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2023
Tangible Fixed Assets - -
Fixed Assets 0.3% 0.3%
Stocks Inventory - -
Debtors - -
Cash Bank In Hand - -
Current Assets 99.7% 99.7%
Creditors Due Within One Year 22.1% 22.1%
Net Current Assets Liabilities 77.6% 77.6%
Creditors Due After One Year - -
Accruals Deferred Income - -
Provisions For Liabilities Charges - -
Net Assets Liabilities Including Pension Asset Liability - -
Called Up Share Capital - -
Share Capital Allotted Called Up Paid - -
Profit Loss Account Reserve - -
Shareholder Funds 75.1% 75.1%
Capital Employed - -
Total Assets Less Current Liabilities 77.9% 77.9%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2023
Liquidity Ratio 4.5 4.5
Solvency Ratio 4.0 4.0
Reserves to Assets - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2023
Assets 570,004 570,004
Debt 142,176 142,176
Net Assets/Debt 427,828 427,828

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around CB4 0WS
DE NOVO PARTNERS LIMITED
NP-105, ICENTRE HOWARD WAY, INTERCHANGE PARK, NEWPORT PAGNELL, CB4 0WS
XINTERA LIMITED
Leonard Curtis House Elms Square Bury New Road, Whitefield, Greater Manchester, CB4 0WS
CAMBRIDGE CHINA INNOVATION CENTER LIMITED
3B ROSEMARY HOUSE LANWADES BUSINESS PARK, KENNETT, NEWMARKET, CB4 0WS
SPRINGBOARD PRO LTD.
ST JOHN'S INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, CB4 0WS
SILICON SAFE LTD
Townsend House, Crown Road, Norwich, CB4 0WS
CLEAR CHOICE BRANDS LTD
219 THE ROWANS, MILTON, CAMBRIDGE, CB4 0WS
AW EMPLOYMENT LIMITED
St John's Innovation Centre Cowley Road, Milton, Cambridge, CB4 0WS
OUTSIDE THE BOX THINKING LIMITED
24 Lyles Road, Cottenham, Cambridge, CB4 0WS
INTERACTIVE PAGES LIMITED
UNION HOUSE, 111 NEW UNION STREET, COVENTRY, CB4 0WS
RF CREATIONS LIMITED
Unit 66 St. John's Innovation Centre, Cowley Road, Cowley Road, CB4 0WS
Document Filings
Appointment of Dr Philip Henrik Engell Brainin as a director on 12 March 2026
Termination of appointment of Jackie Sarah Mcken as a director on 17 August 2025
Appointment of Mr Julian Michael Stuart Attfield as a secretary on 24 July 2025
Second filing of a statement of capital following an allotment of shares on 12 February 2024
Confirmation statement made on 10 March 2025 with updates
Appointment of Dr Shi Yin Foo as a director on 17 February 2025
Statement of capital following an allotment of shares on 25 January 2025
Statement of capital following an allotment of shares on 5 December 2024
Second filing of a statement of capital following an allotment of shares on 12 February 2024
Second filing of a statement of capital following an allotment of shares on 6 June 2024
Appointment of Miss Laura Kate Davies as a director on 5 September 2024
Termination of appointment of Harry Destecroix as a director on 5 September 2024
Statement of capital following an allotment of shares on 23 August 2024
Statement of capital following an allotment of shares on 6 June 2024
Appointment of Dr Anker Lundemose as a director on 1 April 2024
Second filing of a statement of capital following an allotment of shares on 21 March 2024
Notification of a person with significant control statement
Statement of capital following an allotment of shares on 21 March 2024
Cessation of David Owen Bates as a person with significant control on 12 February 2024
Change of details for Professor David Owen Bates as a person with significant control on 16 December 2022
Confirmation statement made on 10 March 2024 with updates
Statement of capital following an allotment of shares on 12 February 2024
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free